Benitec Biopharma (BNTC) Non-Current Assets (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Non-Current Assets for 7 consecutive years, with $1.2 million as the latest value for Q1 2025.
- Quarterly Non-Current Assets rose 89.42% to $1.2 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $81.2 million through Mar 2025, up 3066.1% year-over-year, with the annual reading at $536000.0 for FY2024, 27.07% down from the prior year.
- Non-Current Assets hit $1.2 million in Q1 2025 for Benitec Biopharma, down from $79.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $79.1 million in Q4 2024 to a low of $439000.0 in Q3 2024.
- Historically, Non-Current Assets has averaged $5.5 million across 5 years, with a median of $930000.0 in 2022.
- Biggest five-year swings in Non-Current Assets: crashed 40.11% in 2023 and later soared 14095.33% in 2024.
- Year by year, Non-Current Assets stood at $1.3 million in 2021, then crashed by 30.7% to $930000.0 in 2022, then plummeted by 40.11% to $557000.0 in 2023, then skyrocketed by 14095.33% to $79.1 million in 2024, then plummeted by 98.48% to $1.2 million in 2025.
- Business Quant data shows Non-Current Assets for BNTC at $1.2 million in Q1 2025, $79.1 million in Q4 2024, and $439000.0 in Q3 2024.